Erste Asset Management Gmb H Sage Therapeutics, Inc. Transaction History
Erste Asset Management Gmb H
- $7.79 Trillion
- Q1 2025
A detailed history of Erste Asset Management Gmb H transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Erste Asset Management Gmb H holds 28,500 shares of SAGE stock, worth $247,380. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,500
Previous 28,500
-0.0%
Holding current value
$247,380
Previous $158 Million
49.46%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding SAGE
# of Institutions
220Shares Held
49.9MCall Options Held
220KPut Options Held
312K-
Black Rock Inc. New York, NY5.22MShares$45.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$44.1 Million0.0% of portfolio
-
Madison Avenue Partners, LP New York, NY4.48MShares$38.9 Million4.6% of portfolio
-
Tig Advisors, LLC New York, NY2.73MShares$23.7 Million1.36% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.09MShares$18.1 Million0.02% of portfolio
About Sage Therapeutics, Inc.
- Ticker SAGE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,422,300
- Market Cap $516M
- Description
- Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...